Form 10Q
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                   Quarterly Report Under Section 13 or 15 (d)
                     of the Securities Exchange Act of 1934

For Quarter Ended:          Nov. 30, 1996
                           ---------------

Commission File Number:      0-11050
                            --------------

                              Mammatech Corporation
              ---------------------------------------------------
             (Exact name of registrant as specified in its charter)


          Florida                                         59-2181303
-------------------------------                       --------------------
(State or other jurisdiction of                        (I.R.S. Employer
incorporation or organization)                        Identification Number)


930 N.W. 8th Avenue, Gainesville, Florida                   32601
-----------------------------------------                 --------
(Address of principal executive offices)                 (Zip Code)


                                 (904) 375-0607
               --------------------------------------------------
              (Registrant's telephone number, including area code)


Indicate by check mark whether the registrant (1) has filed all reports required
to be filed  by  section  13 or 15 (d) of the  Securities  Exchange  Act of 1934
during the preceding 12 months (or for such shorter  period that the  registrant
was  required  to file such  reports),  and (2) has been  subject to such filing
requirements for the past ninety days. Yes        No   X
                                           -----    -----

Indicate the number of shares  outstanding  of each of the  issuer's  classes of
common stock, as of the latest practicable date:

                                         Number of shares outstanding on

                                                  Nov. 30, 1996
                                         --------------------------------
                                            100,352,500 shares of which
                                            6,208,500 are treasury shares
TITLE OF EACH CLASS
-----------------------------
Common stock $.0001 par value

The total number of pages of this report is 11.








                                       -1-

<PAGE>


                              Mammatech Corporation

                                      INDEX
--------------------------------------------------------------------------------

PART I.

     FINANCIAL INFORMATION                                           PAGE NO.


         Item 1.  Financial Statements

         Statements of Operations for Three Months
         Ended Nov. 30, 1996 and Nov. 30, 1995....................      3

         Balance Sheets for Nov. 30, 1996 and
         August 31, 1996..........................................     4-5

         Statement of Cash Flow for the Quarter
         Ended Nov. 30, 1996......................................      6

         Statement of Cash Flow for the Quarter
         Ended Nov. 30, 1996......................................      7

         Notes to Financial Statements for the Quarter
         Ended Nov. 30, 1996......................................      8


         Item 2.  Management's Discussion and Analysis of
         Financial Conditions and Results of Operations...........      9


PART II.  OTHER INFORMATION


         Item 6.  Exhibits and Reports on Form 8-K................      10

         SIGNATURES...............................................      11
















                                       -2-

<PAGE>

                              Mammatech Corporation
                            Statements of Operations
                                   (Unaudited)

                                                      Three Months Ended
                                              November, 1996      November, 1995
                                              --------------      --------------

Sales, net                                    $      97,883       $      72,059

Cost of sales                                 $      28,859       $      22.733
                                              -------------       -------------


Gross Profit                                         69,024              49,326

Selling,general and
 administrative expense                       $      52,769       $      65,988
                                              -------------       -------------

Operating Income (Loss)                       $      16,255       $     (16,672)

Other income
(expense)
Reimbursement (SBIR Grant)                                0              26,688
 Interest & Dividend Income                           1,955               1,342
                                              -------------       -------------
                                                      1,955              28,030

Net Income before taxes                       $      18,210       $      11,358
Provision for income taxes                            3,985               2,186
Net Income before                                    22,195              13,544
  Extraordinary item

Operating loss carryforward                           3,985               2,186


NET INCOME (LOSS)                                    18,210              11,358
                                              =============       =============

Net income (loss) per share                           .0002               .0002
                                              =============       =============

Weighted average shares                         100,352,500         100,352,500
                                              =============       =============










    The accompanying notes are an integral part of the financial statements.





                                       -3-

<PAGE>

                              Mammatech Corporation

                                 Balance Sheets


                                                    Nov. 30, 1996  Aug. 31, 1996
                                                    (Unaudited)      (Audited)
                                                    -----------      ---------
ASSETS
------

  Cash and Cash Equivalents                            $198,696         $179,651

  Accounts receivable:
    Trade                                                29,431           34,287
    Other                                                 3,233            3,246

  Inventory                                              96,737           94,903
  Other current assets

  Total Current Assets                                  328,097          312,087
  ---------------------                                --------         --------

Property and equipment                                   49,277           52,277

Other assets:

    Other investments

Patents, trademarks, and
    other intangibles, net of
    accumulated amortization
    of $59,148 and $53,080
    respectively                                          1,561            1,561
                                                       --------         --------

    Total other assets                                    1,561            1,561
    --------------------                               --------         --------

TOTAL ASSETS                                           $378,935         $365,925
                                                       ========         ========






    The accompanying notes are an integral part of the financial statements.






                                       -4-

<PAGE>
                              Mammatech Corporation
                                 Balance Sheets
                              As of August 31, 1996
                                and Nov. 30, 1996
                                   (continued)

                                             Nov.1996            Aug 1996
                                             --------            --------

LIABILITIES AND STOCKHOLDERS' EQUITY
------------------------------------

CURRENT LIABILITIES                   
-------------------                   
Accounts payable-trade                     $    23,219         $    21,594
Customer deposits                                  -0-                 -0-
Accrued payable-officer                          8,630               8,630
Short term debt                                  2,526               3,325
Accrued expenses                                49,598              55,624
                                           -----------         -----------


TOTAL CURRENT LIABILITIES                       83,973              89,173
                                           -----------         -----------


COMMITMENTS
  Long term debt                                 9,223               9,223

Stockholders' equity:

  Common stock, par value $.0001;
  200,000,000 shares authorized;
  100,352,500 shares issued
  and outstanding                          $    10,035         $    10,035

  Additional paid-in capital                 2,809,594           2,809,594
  Accumulated deficit                       (2,385,839)         (2,404,049)
                                           -----------         -----------
                                               433,790             415,580


  Treasury stock at cost,
     6,208,500 shares                         (148,051)           (148,051)
                                           -----------         -----------
                                               285,739             267,529
                                           -----------         -----------


TOTAL LIABILITIES AND
STOCKHOLDERS' EQUITY                       $   378,935          $   365,925
                                           ===========          ===========


        The accompanying notes are an integral part of these statements







                                       -5-

<PAGE>

                              Mammatech Corporation
                             Statement of Cash Flow
                           For the Three Months Ending
                                  Nov. 30, 1996



Net cash flow from operating activities                           $ 16,045
                                                                  ========
Investing Activities:

Purchase of fixed assets                                             3,000
Financing activities:
    Issuance of treasury shares                                       -0-

Net increase (decrease) in cash                                     19,045

         Beginning cash                                            179,651
                                                                  --------

Ending cash                                                       $198,696
                                                                  ========





    The accompanying notes are an integral part of the financial statements.





















                                       -6-

<PAGE>

                             Mammatech Corporation
                             Statement of Cash Flow
                          For the Three Months Ending
                                 Nov. 30, 1995


Net cash flow from operating activities                            $  5,195
                                                                   ========

Investing Activities:

Purchase of fixed assets                                             (5,116)
Financing activities:
    Issuance of treasury shares                                         -0-

Net increase (decrease) in cash                                         (79)

    Beginning cash                                                  136,702
                                                                    -------

Ending cash                                                        $136,623
                                                                   ========






    The accompanying notes are an integral part of the financial statements.

                                      -7-



<PAGE>


                              Mammatech Corporation
                          Notes to Financial Statements
                                  Nov. 30, 1996


Note 1.   In the opinion of the Company,  the accompanying  unaudited  financial
          statements   contain  all  adjustments   (consisting  of  only  normal
          recurring accruals) necessary to present fairly the financial position
          as of Nov.  30,  1996,  and the results of  operations  and changes in
          financial position for the three months ended Nov. 30, 1996.


Note 2.   Loss per  share is based on the  weighted  average  number  of  shares
          outstanding during each period.

Note 3.   Gives effect to the Company's  repurchasing  7,558,500 shares of stock
          from shareholders for treasury stock.




























                                       -8-

<PAGE>

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITIONS AND RESULTS OF OPERATION FOR MAMMATECH CORPORATION

Results for the first quarter of Fiscal 1997 are encouraging and consistent with
the Company's established  growth trajectory. Net sales increased 23.3% from the
previous  quarter and were 35.8%  greater  than the first  quarter of 1996.  The
operating costs of $52,769 represents a decrease of 25% relative to the previous
quarter and 20% in comparison  to the same period last year.  The net income for
the  quarter  was 60% above  that of the first  quarter  of 1996.  A  meaningful
comparison  to the net income of the last quarter of 1996 is not possible  since
various end-of-year charge-offs resulted in a loss for that period.

The Company  continued to expand its customer  base during the first  quarter of
1997. Substantial orders were received from the Bureau of Health of the State of
Maine and the Indiana  Department  of Health,  both as a result of the Company's
participation  in the BCCCP  Programs  of various  states that are funded by the
Center for  Disease  Control.  In  addition,  The  College of Nursing at Florida
International  University and the Department of Health  Education at Mississippi
State University  placed sizeable orders for training  materials.  Finally,  the
Anti-Cancer Council of Victoria, Australia again placed a large order for breast
models.  This signals a revival of their  program  which began in mid 1980's but
had been dormant for several years.

The most significant development of the quarter was the purchase of MammaCare(R)
Specialist  training  by  several  military  installations  on the  East  Coast.
MammaCare(R)  Specialist  training is a four or five day intensive program which
prepares a nurse or other  health  care  professional  to  provide  MammaCare(R)
training  to either  patients  or other  health  care  professionals,  including
physicians. In the case of the military installations,  the intent is to provide
superior clinical breast  examination to female personnel and female dependents,
so trained  specialists  will be  upgrading  the skills of  physicians  at their
facilities.

With  the  exception  of  a  small  note  to  an  unaffiliated  supplier  for  a
manufacturing  facility,  the  Company  remains  debt free and has no  immediate
liquidity  problems.  It continues to seek a  relationship  with a larger health
care organization.



                                       -9-

<PAGE>


PART II - OTHER INFORMATION
---------------------------

Item 6.    Exhibits and Reports on Form 8-K

   (a.)    Exhibits - None

   (b.)    There were no reports filed on Form 8-K during the three
           months ending Nov. 30, 1996.















                                      -10-

<PAGE>


                                      10-Q

                    For the three months ended Nov. 30, 1996

                                   Signatures

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.

MAMMATECH CORPORATION
---------------------

DATE: JANUARY 9, 1997                  BY: /S/  HENRY S. PENNYPACKER
                                           ------------------------------------
                                           Henry S. Pennypacker, President
                                           and Director

BY: /S/  MARY SELLERS
    ----------------------------
    Mary Sellers, Treasurer and
    Chief Financial Officer





                                      -11-